|Back to main|
CME Group Now Rated a “Buy” at UBS (CME)
6/10/2011 8:37:00 AM
Futures exchange operator CME Group Inc. ( CME ) on Friday saw its rating and price target boosted by analysts at UBS.
The firm said it upgraded CME from "Neutral" to "Buy" with a $318 price target. That target suggests a 20% upside to the stock's Thursday closing price of $266.25.
Analysts at UBS noted the company has both cyclical and secular growth potential.
CME shares rose $3.75, or +1.4%, in premarket trading Friday.
The Bottom Line
CME Group Inc. ( CME ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.